中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Lai, Shuzhen;  Chen, Yuan Yuan Yuan;  Li, Peijing;  Jiang, Fagui;  Liu, Xiaohui;  Tao, Changjuan;  Huang, Jing;  Tang, Yiqiang;  Liu, Zhigang;  Shen, Guoping;  Li, Chaoming;  Xie, Tieming;  Lu, Fangxiao;  Liu, Guihong
收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Peijing;  Chen, Yuan Yuan Yuan;  Lai, Shuzhen;  Jiang, Fagui;  Liu, Xiaohui;  Tao, Changjuan;  Wang, Lei;  Liu, Guihong;  Huang, Jing;  Tang, Yiqiang;  Liu, Zhigang;  Shen, Guoping;  Li, Chaoming;  Xie, Tieming;  Lu, Fangxiao
收藏  |  浏览/下载：54/0  |  提交时间：2022/01/10